Latest Liquidity News

Buru Energy has enhanced the Rafael Gas Project’s mid-case value by over 45% through new engineering insights, while securing A$5.3 million to advance development. The company delayed appraisal drilling to 2027 to optimise funding and project design, and navigates a leadership change with CEO Thomas Nador stepping down.

Aurora Energy Metals has completed the sale of its Aurora Uranium Project to Eagle Nuclear Energy, receiving US$17.1 million in equity and holding rights to up to US$10 million in milestone payments plus a 1% royalty. The transaction strengthens Aurora's balance sheet and ushers in a new leadership phase.

QuickFee reported a 9% normalised revenue decline in Q3 FY26, driven by US finance weakness post-US Pay Now sale, while Australian legal disbursement funding surged, underpinning confidence in FY26 earnings guidance.

Butn Limited surged to record monthly originations and revenue in March 2026, while cutting costs and completing a share buy-back, underscoring its drive to scale embedded SME funding solutions.

Pantera Minerals has seen a 37% uplift in the valuation of its EnergyX stake following an increase in EnergyX’s Regulation A raise price to US$13 per share, reflecting operational progress and stronger market confidence.

Mitchell Services Limited (ASX: MSV) reported a 110% jump in quarterly EBITDA for Q3 FY26, driven by improved weather and stable operations, alongside a solid balance sheet with net debt under $1 million post-dividend.

Nutritional Growth Solutions (ASX: NGS) has completed a major operational reset, achieving normalised profitability, eliminating all debt, and replenishing inventory to support renewed growth.

MA Credit Income Trust has approved an on-market buy-back of its units, adding a flexible tool to its capital management arsenal amid evolving market conditions.

Stanmore Resources defied a four-year low in metallurgical coal prices to deliver record saleable production and robust cash flow in 2025, while maintaining a strong safety record and advancing key development projects.

Lumos Diagnostics has secured a key FDA 510(k) clearance with CLIA waiver for its FebriDx rapid test, unlocking a US$1 billion-plus market opportunity and triggering milestone payments exceeding US$6 million. The company reported a 37% revenue jump in Q3 FY26, supported by a A$20 million placement and ongoing clinical and development projects.

Fitch Ratings has maintained Karoon Energy’s credit ratings while revising its outlook to Negative, citing operational disruptions and production decline risks despite solid liquidity and manageable debt. Karoon is actively working on restoring production at key assets with updates expected in its upcoming quarterly report.

Calix Limited has secured an initial A$5.7 million payment following the completion of its lithium Mid-Stream Project restructure with PLS Group, releasing $11.4 million in capital and shifting to a capital-light licensing model.